Last reviewed · How we verify

NCT05816876

Muscle Function, Exercise Capacity and Physical Activity Level in Primary Ciliary Dyskinesia and Kartagener Syndrome

Completed Last updated 18 April 2023
What this trial tests

trial in Primary Ciliary Dyskinesia in 65 participants. Completed in 1 February 2023.

Timeline
10 November 2016
Primary endpoint
20 January 2023
1 February 2023

Quick facts

Lead sponsorGazi University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment65
Start date10 November 2016
Primary completion20 January 2023
Estimated completion1 February 2023
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Gazi University

Who can join

Adults 6 to 18, any sex, with Primary Ciliary Dyskinesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Studies evaluating respiratory and peripheral muscle functions in PCD patients and comparing them with healthy children are limited in the literature. There is no study investigating pulmonary and extrapulmonary effects in Kartagener syndrome, which is a form of PCD. The aim of our study is to compare respiratory functions, respiratory muscle strength and endurance, exercise capacity, peripheral muscle strength, physical activity level and quality of life in patients with PCD, Kartagener syndrome and healthy children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Primary Ciliary Dyskinesia

Currently open trials in the same condition.

Other Gazi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05816876.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing